AURYXIA (ferric citrate) Keryx biopharms Patent: 9,050,316 Expiration: Feb 18, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug Patent Expirations for the Week of February 18, 2024 appeared first on DrugPatentWatch - Make Better Decisions.